You are here:

MS in the media - 10 June 2016

Published on

4 - 10 June 2016

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.

Older people with MS

A study found that older people with MS have a greater reduction in physical function than people of a similar age who don't have the condition.  Presented at the CMSC conference

Source: MS News Today

MS Trust link: More from CMSC

Opicinumab (anti-lingo-1) trial disappointing

A trial comparing opicinumab to Avonex in people with relapsing remitting or secondary progressive MS failed to find any improvement in disability or slowdown in disability progression.

Source: Biogen press release
Source: National MS Society (USA)

MS Trust link: Opicinumab (anti-lingo-1)

Stem cell trial shows long-term benefits

A Canadian study of an aggressive stem cell treatment in 24 people found that it stopped relapses over a follow up period of up to almost 13 years.  The treatment also greatly reduced new lesions and disease progression, with a third of participants showing improving EDSS 338 scores.  One person died due to the treatment.

Source: Guardian
Source: Daily Telegraph
Source: BBC
Source: National MS Society (USA)

MS Trust link: A short guide to stem cell therapy

Print this page